|
|
| Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
| Bank Loan Ratings | 6.00 | ACUITE B | Downgraded | Issuer not co-operating* | - |
| Total Outstanding | 6.00 | - | - |
|
Rating Rationale |
|
Acuité has downgraded the long-term rating to 'ACUITE B' (read as ACUITE B) from 'ACUITE B+' (read as ACUITE B Plus) on the Rs.6.00 crore bank facilities of Gloria Alluminium India Private Limited (GAIPL). Acuite had sent repeated reminders to the company for sharing critical information for surveillance of the ratings. But despite multiple requests, the company has remained non-cooperative in providing the information. The rating is now flagged as “Issuer Not Cooperating” and is based on the best information available. The downgrade is on account of information risk.
|
| About the Company |
|
GAIPL incorporated in the year 2016, is engaged in the manufacturing of aluminium extrusions. The manufacturing process for aluminium extrusions involves the heating and moulding of aluminium scraps and ingots as per the requirements of the client. The manufacturing unit of the company is located in Pune, Maharashtra. GAIPL is promoted by Agarwal family led by Mr. R.M. Agarwal, Mr. P.M. Agarwal.
|
| Unsupported Rating |
|
Not Applicable
|
| Non-cooperation by the issuer/borrower |
|
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. Acuité believes that information risk is a critical component in such ratings, and non cooperation by the issuer along with unwillingness to provide information could be a sign of potential deterioration in its overall credit quality. This rating is therefore being flagged as “Issuer not cooperating”, in line with prevailing SEBI regulations and Acuité’s policies.
|
| Limitation regarding information availability |
|
The rating is based on information available from sources other than the issuer/borrower (in the absence of information provided by the issuer/borrower). Acuité endeavoured to gather information about the entity/industry from the public domain. Therefore, Acuité cautions lenders and investors regarding the use of such information, on which the indicative credit rating is based.
|
| Rating Sensitivities |
|
No information provided by the issuer / available for Acuite to comment upon.
|
| Liquidity Position |
|
No information provided by the issuer / available for Acuite to comment upon.
|
| Outlook: Not Applicable |
| |
| Other Factors affecting Rating |
|
None
|
| Particulars | Unit | FY 22 (Actual) | FY 21 (Actual) |
| Operating Income | Rs. Cr. | 54.92 | 20.09 |
| PAT | Rs. Cr. | 1.82 | (1.22) |
| PAT Margin | (%) | 3.31 | (6.09) |
| Total Debt/Tangible Net Worth | Times | 4.17 | 9.85 |
| PBDIT/Interest | Times | 5.57 | 0.09 |
| Status of non-cooperation with previous CRA |
|
Not Applicable
|
| Any other information |
|
None
|
| Applicable Criteria |
|
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm |
| Note on Complexity Levels of the Rated Instrument |
|
In order to inform the investors about complexity of instruments, Acuité has categorized such instruments in three levels: Simple, Complex and Highly Complex. Acuite’ s categorisation of the instruments across the three categories is based on factors like variability of the returns to the investors, uncertainty in cash flow patterns, number of counterparties and general understanding of the instrument by the market. It has to be understood that complexity is different from credit risk and even an instrument categorized as 'Simple' can carry high levels of risk. For more details, please refer Rating Criteria “Complexity Level Of Financial Instruments” on www.acuite.in
|
|
| |
|
|
|||||||||||||||||||||||||||
|
|
Contacts |
|
|
|
About Acuité Ratings & Research |
